Medical Research Support backs third-party investigators studying Illumina products and technology in four clinical areas to advance genomics research and its use in areas of clinical need.
Funder: Illumina
Due Dates: No application deadline stated
Funding Amounts: Financial and/or in-kind support; requests assessed against local fair market value
Summary: Supports third-party clinical research using Illumina products or technology in four clinical areas.
Key Information: Non-clinical studies using animal models are out of scope.
Illumina’s Medical Research Support program backs third-party studies involving its research-use-only or in vitro diagnostic products and technology. Its clinical areas of interest are genetic disease testing, infectious disease, oncology, and reproductive health. The program is part of Illumina’s effort to advance genomics research and its use in areas of clinical need.
Support takes the form of a medical research grant, investigator-sponsored research, or collaborative scientific research. For research grants and investigator-sponsored studies, the investigator initiates and leads the work. In collaborative research, Illumina and the investigator develop objectives together, with the investigator leading study design and execution alongside Illumina.